Broadview Ventures — 2024 Investments

3 investments dated 2024 · listed companies and verified rows first · show all

AtaCor Medicalatacor.comSeries C · Apr 2024 · $28M

AtaCor Medical develops extravascular lead systems for cardiac rhythm management, including a novel extravascular defibrillation lead for EV-ICD therapy and an implantable, extracardiac pacemaker.

HardwareHealthtechMedical Devices

Alan(Co-founder & Vice President of Clinical, Regulatory & Quality)

Co-investorsArboretum Ventures BayMed Venture Partners Catalyst Health Ventures Hatteras Venture Partners

Isomabisomab.bio inSeed · Feb 2024 · $9M

Isomab develops first-in-class antibody therapies targeting specific VEGF-A isoforms to restore blood vessel growth and improve blood flow in cardiovascular diseases.

BiotechHealthtechMedical DevicesNottingham, GB

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Alveron Pharma

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.